5,6,7,7a-tetrahydro-4H-thieno[3,2-c]pyridin-2-one,4-methylbenzenesulfonic acid

We are 5,6,7,7a-tetrahydro-4H-thieno[3,2-c]pyridin-2-one,4-methylbenzenesulfonic acid CAS:952340-39-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:5,6,7,7a-tetrahydro-4H-thieno[3,2-c]pyridin-2-one,4-methylbenzenesulfonic acid
CAS.NO:952340-39-5
Synonyms:
5,6,7,7a-tetrahydro-4H-thieno[3,2-c]-pyridin-2-one toluene-4-sulfonate
5,6,7,7a-tetrahydro-4H-thieno[3,2-c]-pyridin-2-one p-toluenesulfonate
5,6,7,7a-tetrahydro-4H-tieno[3,2-c]pyridine-2-on toluene-4-sulfonate
5,6,7,7a-tetrahydro-4H-tieno[3,2-c]-pyridine-2-one toluene-4-sulfonate
5,6,7,7a-Tetrahydrothieno[3,2-c]pyridin-2(4H)-one 4-methylbenzenesulfonate
2-oxo-2,4,5,6,7,7a-hexahydrothieno[3,2-c]pyridine-p-toluenesulfonate
5,6,7,7a-tetrahydro-thieno-[3,2-c]-pyridin-2(4H)-one p-toluenesulfonate

Molecular Formula: C14H17NO4S2
Molecular Weight: 327.41900

Physical and Chemical Properties:
Density:/
Boiling point:593.1ºC at 760 mmHg
Melting point:/
Flash point:312.5ºC
Refractive index:/

Specification:
Appearance: White  crystalline powder
Purity:≥98%
Impurity: Not more than 2.0%
Moisture Content: Not more than 1.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Prasugrel hydrochloride CAS:389574-19-0

5,6,7,7a-tetrahydro-4H-thieno[3,2-c]pyridin-2-one,4-methylbenzenesulfonic acid


Related News: Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).2,4,6-Trichlorophenol CAS:88-06-2 Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)acetonitrile Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.DL-Histidine Monohydrochloride Monohydrate Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells.

Related Products
Product Name
2-Methoxyethanol View Details
Diethanolamine View Details
diethoxy-methyl-[3-(oxiran-2-ylmethoxy)propyl]silane View Details
6-chloro-1-hydroxybenzotriazole manufacturer ethyl (2S,5R)-5-[(benzyloxy)amino]piperidine-2-carboxylate ethanedioate manufacturer DL-Histidine Monohydrochloride Monohydrate manufacturer 2-Bromoethyl ethyl ether manufacturer 2-Fluoro-6-nitro-n-phenylbenzamide manufacturer